World Demand for Wound Management Products Will Reach $28.8 Billion

World demand for wound management products will expand 4.6 percent annually to $28.8 billion in 2013, serving a $9.2 trillion global health care industry.  The best growth opportunities will emerge in tissue sealants, foam and alginate wound dressings, growth factor healing agents, bioengineered tissue substitutes and negative pressure therapy systems.  China will form the fastest expanding wound management market as strong economic growth enables the country to upgrade and expand its medical delivery system.  The United States is the largest and most diversified global consumer of wound management supplies and devices, reflecting the advanced nature of professional health care treatment, the widespread health insurance coverage for basic and essential health care services, and physician preferences for high value-added products. These and other trends, including market share and product segmentation, are presented in World Wound Management Products, a new study from The Freedonia Group, Inc., a Cleveland-based industry research firm.

World demand for wound closures will reach $11.1 billion in 2013, up 3.5 percent annually from 2008.  Advances in minimally invasive surgeries and the increasing substitution of drug therapy for surgical procedures will moderate faster growth.  Tissue sealants will provide the fastest growth among wound closures, spurred by improvements in available products and speed of application advantages in the closing of minor surgical incisions and wounds.  Nonetheless, sutures and staples will continue to dominate wound closure demand based on well-established performance results in major surgery.

Bandages are forecast to post global demand of $7.9 billion in 2013, up 4.3 percent annually.  Global demand for wound dressings will expand 5.4 percent annually to $3.9 billion in 2013.  Led by anti-infectives and growth factors, world demand for wound healing agents will increase 6.4 percent annually to $1.6 billion in 2013.  Global demand for other wound management products will expand 7.3 percent annually to $4.3 billion in 2013.  The best commercial opportunities will evolve in bioengineered tissue substitutes and negative pressure therapy systems.  Ongoing advances in materials and production technologies will broaden applications for bioengineered tissue substitutes as replacements or complements to skin grafts in burn and leg ulcer treatment. 

The Freedonia Group is a leading international business research company, founded in 1985, that publishes more than 100 industry research studies annually. This industry analysis provides an unbiased outlook and a reliable assessment of an industry and includes product segmentation and demand forecasts, industry trends, demand history, threats and opportunities, competitive strategies, market share determinations and company profiles.